That will empower them to be engaged partners in their care.“ I don't take care of diabetes,” Dr. ... Refer to a specialist and follow up. Any patient with prediabetes, diabetes or hypertension should see an ophthalmologist.
QD: News Every Day--Teen diabetes rate more than doubles in a decade. ... Prediabetes/diabetes rates in teenagers increased from 9% to 23% in the past decade, researchers reported in a study.
If you want to lower your risk for diabetes and heart disease, exercise is essential. ... In the U.S., there are more persons with diabetes than ever before.
Lixisenatide (Adlyxin), a once-daily injection to improve glycemic control in adults with type 2 diabetes. ... In 10 trials of 5,400 patients, the glucagon-like peptide 1 receptor agonist improved HbA1c levels, both as a stand-alone therapy and with
A Saturday-morning session will look at glucose control and HbA1c goals in type 2 diabetes.
QD: News Every Day--Residents aren't learning how to treat diabetes properly. ... Internal medicine residency programs aren't doing enough to teach quality treatment for diabetes, concluded a study, which doesn't bode well for doctors who will eventually
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease. ... It should not be
A talk at Tuesday's“ Diabetes for the Internist” precourse reviewed some of the most significant recent advances in insulin, including new concentrations and combinations with other medications, new delivery mechanisms,
There were 13,284 incident cases of type 2 diabetes among 352,384 participants with follow-up periods ranging from four to 22 years. ... All participants were diabetes free at baseline. Asian (Chinese and Japanese) populations averaged three to four
Progression of type 2 diabetes is almost inevitable, and with it usually comes a need for different medications. ... Peters said. Metformin is the preferred first-line treatment for type 2 diabetes.